These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21543497)

  • 1. Protective effects of broadly neutralizing immunoglobulin against homologous and heterologous equine infectious anemia virus infection in horses with severe combined immunodeficiency.
    Taylor SD; Leib SR; Wu W; Nelson R; Carpenter S; Mealey RH
    J Virol; 2011 Jul; 85(13):6814-8. PubMed ID: 21543497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of a rare neutralization-resistant variant following passive transfer of convalescent immune plasma in equine infectious anemia virus-challenged SCID horses.
    Taylor SD; Leib SR; Carpenter S; Mealey RH
    J Virol; 2010 Jul; 84(13):6536-48. PubMed ID: 20392850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive immunity is the primary force driving selection of equine infectious anemia virus envelope SU variants during acute infection.
    Mealey RH; Leib SR; Pownder SL; McGuire TC
    J Virol; 2004 Sep; 78(17):9295-305. PubMed ID: 15308724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of lentiviral infection in vivo in the absence of adaptive immune responses.
    Schwartz EJ; Vaidya NK; Dorman KS; Carpenter S; Mealey RH
    Virology; 2018 Jan; 513():108-113. PubMed ID: 29055819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune reconstitution prevents continuous equine infectious anemia virus replication in an Arabian foal with severe combined immunodeficiency: lessons for control of lentiviruses.
    Mealey RH; Fraser DG; Oaks JL; Cantor GH; McGuire TC
    Clin Immunol; 2001 Nov; 101(2):237-47. PubMed ID: 11683583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of low-dose recombinant human IL-2 to support the survival of virus-specific CTL clones infused into severe combined immunodeficient foals: lack of correlation between in vitro activity and in vivo efficacy.
    Mealey RH; Littke MH; Leib SR; Davis WC; McGuire TC
    Vet Immunol Immunopathol; 2008 Jan; 121(1-2):8-22. PubMed ID: 17727961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study on an attenuated Chinese EIAV vaccine inducing broadly neutralizing antibodies.
    Meng Q; Lin Y; Ma J; Ma Y; Zhao L; Li S; Liang H; Zhou J; Shen R; Zhang X; Shao Y
    Arch Virol; 2011 Aug; 156(8):1455-62. PubMed ID: 21499906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine specificity of equine infectious anaemia virus gp90-specific antibodies associated with protective and enhancing immune responses in experimentally infected and immunized ponies.
    Grund CH; Lechman ER; Pezzuolo NA; Issel CJ; Montelaro RC
    J Gen Virol; 1996 Mar; 77 ( Pt 3)():435-42. PubMed ID: 8601778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus.
    Raabe ML; Issel CJ; Montelaro RC
    Virology; 1999 Jul; 259(2):416-27. PubMed ID: 10388665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding virus-host dynamics following EIAV infection in SCID horses.
    Ciupe SM; Schwartz EJ
    J Theor Biol; 2014 Feb; 343():1-8. PubMed ID: 24252283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic T lymphocytes and neutralizing antibody in the control of equine infectious anemia virus.
    McGuire TC; Fraser DG; Mealey RH
    Viral Immunol; 2002; 15(4):521-31. PubMed ID: 12513924
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus.
    Issel CJ; Horohov DW; Lea DF; Adams WV; Hagius SD; McManus JM; Allison AC; Montelaro RC
    J Virol; 1992 Jun; 66(6):3398-408. PubMed ID: 1316455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection.
    Rwambo PM; Issel CJ; Adams WV; Hussain KA; Miller M; Montelaro RC
    Arch Virol; 1990; 111(3-4):199-212. PubMed ID: 2162160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-neutralizing and subclass characteristics of antibody from horses with equine infectious anemia virus.
    O'Rourke KI; Perryman LE; McGuire TC
    Vet Immunol Immunopathol; 1989 Nov; 23(1-2):41-9. PubMed ID: 2559537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody escape kinetics of equine infectious anemia virus infection of horses.
    Schwartz EJ; Nanda S; Mealey RH
    J Virol; 2015 Jul; 89(13):6945-51. PubMed ID: 25878104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern.
    Lin YZ; Shen RX; Zhu ZY; Deng XL; Cao XZ; Wang XF; Ma J; Jiang CG; Zhao LP; Lv XL; Shao YM; Zhou JH
    Antiviral Res; 2011 Nov; 92(2):292-304. PubMed ID: 21893100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus.
    Hammond SA; Raabe ML; Issel CJ; Montelaro RC
    Virology; 1999 Sep; 262(2):416-30. PubMed ID: 10502520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T lymphocytes in protection against equine infectious anemia virus.
    McGuire TC; Fraser DG; Mealey RH
    Anim Health Res Rev; 2004 Dec; 5(2):271-6. PubMed ID: 15984338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection.
    Perryman LE; O'Rourke KI; McGuire TC
    J Virol; 1988 Aug; 62(8):3073-6. PubMed ID: 2839723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of an equine infectious anemia virus Env-pseudotyped reporter virus.
    Tallmadge RL; Brindley MA; Salmans J; Mealey RH; Maury W; Carpenter S
    Clin Vaccine Immunol; 2008 Jul; 15(7):1138-40. PubMed ID: 18448619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.